De Novo Metastatic Prostate Cancer
Showing 1 - 25 of >10,000
Prostate Cancer, Oligometastatic Disease Trial in United States (Prostate radiation (XRT), Systemic Therapy, Stereotactic
Recruiting
- Prostate Cancer
- Oligometastatic Disease
- Prostate radiation (XRT)
- +2 more
-
Baltimore, Maryland
- +4 more
Oct 10, 2022
Prostate Cancer Metastatic Trial in France (Darolutamide 300 mg, Placebo, Androgen deprivation therapy)
Recruiting
- Prostate Cancer Metastatic
- Darolutamide 300 mg
- +2 more
-
Avignon, France
- +44 more
Sep 28, 2022
Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Not yet recruiting
- Metastatic Prostate Cancer
- Castration-Sensitive Prostate Cancer
- apalutamide
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Feb 4, 2023
Prostate Cancer, Radiotherapy Side Effect, Metastatic Cancer Trial in Umeå (Moderate hypo-fractionation,
Recruiting
- Prostate Cancer
- +2 more
- Moderate hypo-fractionation
- Ultra-hypo-fractionation
-
Umeå, SwedenCancercenter University hospital of Umeå
Nov 1, 2022
Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)
Not yet recruiting
- Prostate Cancer
- +2 more
- Androgen deprivation therapy (ADT)
- +3 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023
Germline and Somatic Pathogenic Variants in de Novo Metastatic
Active, not recruiting
- Metastatic Breast Cancer
- NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
-
Athens, GreeceEvangelia Moirogiorgou
Mar 7, 2023
Breast Tumors, Treatment, Metastatic Breast Cancer Trial (surgical treatment 1, surgical treatment 2, Systemic therapy)
Not yet recruiting
- Breast Neoplasms
- +3 more
- surgical treatment 1
- +2 more
- (no location specified)
Jul 17, 2022
Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)
Recruiting
- Prostate Cancer
- Hypoxia
- Optional non-IMP pimonidazole
- +8 more
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Jan 26, 2023
Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)
Recruiting
- Metastatic Prostate Cancer
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Sep 17, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T Injection
- (no location specified)
Nov 10, 2023
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)
Not yet recruiting
- Metastatic Hormone-Sensitive Prostate Cancer
- Rezvilutamide
- +2 more
- (no location specified)
Nov 10, 2023
Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body
Recruiting
- Prostate Cancer Metastatic
- +2 more
- stereotactic body radiotherapy
- +2 more
-
Umeå, Umea, Sweden
- +1 more
May 19, 2022
Metastatic Breast Cancer Trial in Ankara (radiotherapy)
Recruiting
- Metastatic Breast Cancer
- radiotherapy
-
Ankara, TurkeyLutfi Dogan
Apr 19, 2022
A Journey Into Participation Patterns Among Metastatic Prostate
Not yet recruiting
- Metastatic Prostate Cancer
-
San Francisco, CaliforniaPower Life Sciences
Aug 18, 2023
Early Detection of de Novo Cancer in Liver Transplant Recipients
Completed
- De Novo Cancer
- Liver Transplant Disorder
- (no location specified)
Aug 5, 2022
PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma Trial in Boston (Supervised Circuit Training)
Not yet recruiting
- PROSTATE CANCER
- +2 more
- Supervised Circuit Training
-
Boston, Massachusetts
- +2 more
Sep 13, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Oct 23, 2023
Optimizing Announcement of Advanced or Metastatic Prostate
Not yet recruiting
- Prostate Cancer
- Animated video
-
Neuilly-sur-Seine, France
- +2 more
Oct 31, 2023
Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)
Recruiting
- Prostate Cancer
- Testosterone Cypionate
- Darolutamide
-
Brasília, Distrito Federal, Brazil
- +4 more
Dec 22, 2022
Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)
Recruiting
- Metastatic Hormone Naive Prostate Cancer
-
Sydney, New South Wales, Australia
- +4 more
Nov 4, 2022
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)
Not yet recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- MK-5684
- +3 more
- (no location specified)
Nov 13, 2023
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023